TITLE

99mTc-HYNIC-TOC scintigraphy in evaluation of active Graves’ ophthalmopathy (GO)

AUTHOR(S)
Hua Sun; Xu-Feng Jiang; Shu Wang; Hao-Yan Chen; Jiao Sun; Pei-Yong Li; Guang Ning; Yong-Ju Zhao
PUB. DATE
June 2007
SOURCE
Endocrine (1355008X);Jun2007, Vol. 31 Issue 3, p305
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
ObjectiveA promising radiopharmaceutical 99mTc-HYNIC-TOC (99mTc-HYNIC-Octreotide) can be applied for somatostatin receptor scintigraphy with the potential to replace Indium-111 labeled somatostatin analogus. Here we evaluate whether orbital 99mTc-HYNIC-TOC scintigraphy can be used as a Graves’ ophthalmopathy (GO) activity parameter to predict the retrobulbar irradiation response.MethodsOrbital 99mTc-HYNIC-TOC scintigraphy was performed on 14 consecutive patients demonstrating moderated to severe Graves’ ophthalmopathy. The patients were treated with retrobulbar irradiation following the octreoscan and the response to this therapy was assessed at 3 months after the start of treatment. The orbital 99mTc-HYNIC-TOC uptake was calculated to assess the effects of treatment.ResultsAmong the 14 GO patients, eight (57.1%) responded to retrobulbar radiotherapy; six (42.9%) showed no change. We compared the eight responders and six non-responders in terms of orbital 99mTc-HYNIC-TOC uptake, using the orbital/occipital ratio. On the 4-h 99mTc-HYNIC-TOC scintigraphy, responders had a higher orbital/occipital uptake ratio than the no-responders (P = 0.001). A significant correlation was found between the orbital/occipital ratio and the clinical activity score (CAS) (P = 0.034). The Receiving-Operator-Characteristic curve showed the best threshold for discriminating active and inactive disease was 1.40 (sensitivity, 100%; specificity, 83.3%). In the responders group, all these eight patients had positive scintigraphy. While there were five patients who had negative scintigraphy in the non-responders group.ConclusionOrbital 99mTc-HYNIC-TOC scintigraphy can be a useful method for the estimation of disease activity and prediction the response to subsequent radiotherapy in GO patient. And the patients with positive octreoscan were more likely to respond to irradiation.
ACCESSION #
27039261

 

Related Articles

  • Morphological imaging in the localization of neuroendocrine gastroenteropancreatic tumors found by somatostatin receptor scintigraphy. Saga, T.; Shimatsu, A.; Koizumi, K.; Ichikawa, T.; Yamamoto, K.; Noguchi, S.; Doi, R.; Ishibashi, M.; Machinami, R.; Nakamura, K.; Sakahara, H.; Endo, K. // Acta Radiologica;May2005, Vol. 46 Issue 3, p227 

    Purpose: To evaluate the necessity of morphological images (MI) in reading somatostatin receptor scintigraphy (SRS) in patients with suspected neuroendocrine gastroenteropancreatic (GEP) tumors.Material and Methods: A Japanese multicenter clinical trial of SRS was...

  • Radiolabelling DOTA-peptides with68Ga. Breeman, Wouter; Jong, Marion; Blois, Erik; Bernard, Bert; Konijnenberg, Mark; Krenning, Eric // European Journal of Nuclear Medicine & Molecular Imaging;Apr2005, Vol. 32 Issue 4, p478 

    Purpose. A new held of interest is the application of 68Ga-labelled DOTA-conjugated peptides for positron emission tomography (PET). The commercially available or house-made generators require time-consuming and tedious handling of the eluate. Radiolabelling at high specific activities without...

  • Cost comparison of In-DTPA-octreotide scintigraphy and Ga-DOTATOC PET/CT for staging enteropancreatic neuroendocrine tumours. Schreiter, Nils; Brenner, Winfried; Nogami, Munenobu; Buchert, Ralph; Huppertz, Alexander; Pape, Ulrich-Frank; Prasad, Vikas; Hamm, Bernd; Maurer, Martin // European Journal of Nuclear Medicine & Molecular Imaging;Jan2012, Vol. 39 Issue 1, p72 

    Purpose: Although somatostatin receptor positron emission tomography (PET)/CT is gaining increasing popularity and has shown its diagnostic superiority in several studies, In-diethylenetriaminepentaacetic acid (DTPA)-octreotide is still the current standard for diagnosis of neuroendocrine...

  • EANM procedure guideline for 32P phosphate treatment of myeloproliferative diseases. Tennvall, Jan; Brans, Boudewijn // European Journal of Nuclear Medicine & Molecular Imaging;Aug2007, Vol. 34 Issue 8, p1324 

    32P phosphate was the first therapeutic radioisotope, used in leukaemia about 70 years ago. Since then, many new agents for haematological proliferations have been introduced successfully. Today there remains a distinct subgroup of elderly patients with polycythaemia vera and essential...

  • Utility of FDG–PET–CT scanning in assessing the extent of disease activity and response to treatment in sarcoidosis. Guleria, Randeep; Jyothidasan, Amudhan; Madan, Karan; Mohan, Anant; Kumar, Rakesh; Bhalla, Ashu Seith; Malhotra, Arun // Lung India;Oct-Dec2014, Vol. 31 Issue 4, p323 

    Background: Radionuclide imaging modalities have increasingly been evaluated in the assessment of organ involvement in sarcoidosis. Fluoro-deoxyglucose positron emission tomography–computed tomography (FDG–PET–CT) scanning has received increasing attention in the recent...

  • Guidelines for lung scintigraphy in children. Ciofetta, Gianclaudio; Piepsz, Amy; Roca, Isabel; Fisher, Sybille; Hahn, Klaus; Sixt, Rune; Biassoni, Lorenzo; De Palma, Diego; Zucchetta, Pietro // European Journal of Nuclear Medicine & Molecular Imaging;Sep2007, Vol. 34 Issue 9, p1518 

    The purpose of this set of guidelines is to help the nuclear medicine practitioner perform a good quality lung isotope scan. The indications for the test are summarised. The different radiopharmaceuticals used for the ventilation and the perfusion studies, the technique for their administration,...

  • Indium-Ill Leukocyte Scintigraphy in Suspected Bowel Ischemia. Dhekne, Ramesh D.; Chatziioannou, Sofia N.; Moore, Warren H.; Ford, Patrick V.; Hochman, F. Lyone // American Journal of Gastroenterology;Aug2000, Vol. 95 Issue 8, p1983 

    OBJECTIVE: The purpose of this study was to evaluate the utility of indium-111 leukocyte (In-111 WBC) scintigraphy in a large number of patients with suspected bowel ischemia. METHODS: All patients who underwent In-111 WBC scintigraphy for possible bowel ischemia over a 4-yr period and had...

  • Hürthle Cell Thyroid Carcinoma Metastatic to the Sigmoid Colon. W. Arnous; S. Beltran; N. Berger; C. Bournaud; J.C. Lifante; J.L. Peix; F. Giammarile; G. Sassolas; F. Borson-Chazot // Thyroid;Feb2007, Vol. 17 Issue 2, p169 

    Prognosis of differentiated thyroid cancer is favorable in the majority of cases. However, distant metastases occur in 10–15% of cases, predominantly in lungs and bones, especially in older patients exhibiting poorly differentiated forms or advanced stages. We report a case history of...

  • Consensus Recommendations for Gastric Emptying Scintigraphy: A Joint Report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Abell, Thomas L.; Camilleri, Michael; Donohoe, Kevin; Hasler, William L.; Lin, Henry C.; Maurer, Alan H.; McCallum, Richard W.; Nowak, Thomas; Nusynowitz, Martin L.; Parkman, Henry P.; Shreve, Paul; Szarka, Lawrence A.; Snape Jr., William J.; Ziessman, Harvey A. // American Journal of Gastroenterology;Mar2008, Vol. 103 Issue 3, p753 

    This consensus statement from the members of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine recommends a standardized method for measuring gastric emptying (GE) by scintigraphy. A low-fat, egg-white meal with imaging at 0, 1, 2, and 4 h after meal...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics